Repligen: Rare Growth In The Biopharma Supplies Industry
Repligen: Rare Growth In The Biopharma Supplies Industry
Source link
Repligen: Rare Growth In The Biopharma Supplies Industry
Source link
November 8, 2024November 8, 2024 Shares of Inox India Ltd. rallied 7%, reaching a day’s high of Rs 1,213.60 on 8th November after the company announced it had won a large contract from the UK-based Highview Power. Inox India secured a contract from UK-based Highview Power for its upcoming…
Welcome to a brand-new episode of ET Market Watch! Your daily dose of market updates, stock movements, trends & more. This is your host Neha V Mahajan, Let’s hear the top 5 highlights of the day: 1. Sensex and Nifty, bounced back on Friday, ending the week over 1% higher mainly driven by gains in…
Some stuff I am reading today morning: US markets close at record highs ( The Street ) India euphoria fizzling out amongst global fund managers ( Rediff ) Trump to impose 25% tariffs on Canada & Mexico ( CNBC ) Navi Mumbai airport to commence operations in Q1 FY26 ( FE ) Cabinet approves waiving…
by Calculated Risk on 4/23/2025 02:17:00 PM From the National Center for Health Statistics: Births: Provisional Data for 2024. The NCHS reports: The provisional number of births for the United States in 2024 was 3,622,673, up 1% from 2023. The general fertility rate was 54.6 births per 1,000 females ages 15–44, an increase of less…
Hello al!l its a week after I released The Fibonacci Scalper Bullish still available for Free download thanks for all the great messages you guys are sending looking forward for all reviews also and further comments the fibonacci scalper will set the fibonacci scale and buying levels according to the look back times is it…
The Autopsy of a Funded Account: How to Structure an EA to Survive Prop Firms Let’s start with an obvious, painful truth that the retail market completely refuses to accept: Prop Firms are not looking for profitable traders. They are looking for flawless risk managers. Every single day in the MQL5 ecosystem, I see the…